KCNK10

Potassium channel subfamily K member 10 · P57789 · KCNK10 on Sugi Atlas →

3,608 patent compounds predicted against KCNK10, 2,305 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL1025150 SCHEMBL1025150 0.49 9/20
SCHEMBL2960950 SCHEMBL2960950 0.49 9/20
SCHEMBL2310710 SCHEMBL2310710 0.41 9/20
SCHEMBL1015553 SCHEMBL1015553 0.57 8/20
SCHEMBL3628210 SCHEMBL3628210 0.42 7/20
SCHEMBL1160810 SCHEMBL1160810 0.47 6/20
SCHEMBL2272471 SCHEMBL2272471 0.55 5/20
SCHEMBL2272483 SCHEMBL2272483 0.55 5/20
SCHEMBL2270296 SCHEMBL2270296 0.53 5/20
SCHEMBL2541283 SCHEMBL2541283 0.47 5/20
SCHEMBL4141917 SCHEMBL4141917 0.40 5/20
SCHEMBL3620188 SCHEMBL3620188 0.47 4/20
SCHEMBL381447 SCHEMBL381447 0.45 4/20
SCHEMBL4056055 SCHEMBL4056055 0.42 4/20
SCHEMBL503539 SCHEMBL503539 0.39 4/20
SCHEMBL1466665 SCHEMBL1466665 0.58 3/20
SCHEMBL2274927 SCHEMBL2274927 0.50 3/20
SCHEMBL3245925 SCHEMBL3245925 0.50 3/20
SCHEMBL5145298 SCHEMBL5145298 0.50 3/20
SCHEMBL5145301 SCHEMBL5145301 0.50 3/20

Clinical trials — most relevant to KCNK10 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Methadone and Hydromorphone on the QT Interval After Anesthesia and Surgery PHASE4RECRUITING
Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study PHASE4COMPLETED
Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease PHASE4NOT_YET_RECRUITING
Mutation-specific Therapy for the Long QT Syndrome PHASE2COMPLETED
A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy PHASE1/PHASE2RECRUITING
Sandostatine® LP and Hyperinsulinism PHASE2COMPLETED
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric Participants With KCNT1-related Epilepsy PHASE2RECRUITING
Long-term Efficacy Study of Sodium Channel Blocker in LQT3 Patients PHASE2COMPLETED
An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome PHASE1/PHASE2COMPLETED
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss PHASE2COMPLETED
Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK PHASE1COMPLETED
Peripheral KV7 Activation for Pain Relief EARLY_PHASE1COMPLETED
The Physiological Effects of Human Ether-a-go-go-Related Gene (hERG)Blockade on Metabolism nanCOMPLETED
Evaluation of the Effects of KCNQ1 Mutation on Insulin Tolerance and Obsessive Compulsive Features in Long QT Romano-Ward Syndrome Patients. nanUNKNOWN
Qatar Cardiovascular Biorepository of AF Patients nanUNKNOWN
A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy nanUNKNOWN
Interaction of Potassium and Genetic Risk Variants on Diabetes Risk nanCOMPLETED
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
Genetic Determinants of Sudden Cardiac Death nanCOMPLETED
Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA) nanUNKNOWN
Characteristics of Andersen-Tawil Syndrome nanCOMPLETED
The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain. nanUNKNOWN
Metabolism of Patients With Genetically Caused Cardiac Arrhythmia nanUNKNOWN
Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development nanCOMPLETED
Gene Study for Infantile Onset Diabetes nanUNKNOWN
The Effects of the Anesthetic Drug Propofol on the Way the Heart Recovers Between Beats nanCOMPLETED
Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients nanUNKNOWN
The Effects of the Anti Nausea Drugs Droperidol and Ondansetron on the Way the Heart Recovers Between Beats nanCOMPLETED
Characteristics of Episodic Ataxia Syndrome nanCOMPLETED
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a KCNK10 binder may also engage these)

ProteinNameSimilarity
Q8BUW1 1.000 Q8BUW1 →
Q9JIS4 0.998 Q9JIS4 →
KCNK2 Potassium channel subfamily K member 2 0.997 landscape →
Q920B6 0.996 Q920B6 →
P34410 0.994 P34410 →
Q3LS21 0.993 Q3LS21 →
P97438 0.992 P97438 →
Q622X0 0.990 Q622X0 →
Q9JL58 0.990 Q9JL58 →
KCNK9 Potassium channel subfamily K member 9 0.990 landscape →
KCNK3 Potassium channel subfamily K member 3 0.989 landscape →
Q23435 0.988 Q23435 →
P97414 0.988 P97414 →
Q22271 0.988 Q22271 →
Q18120 0.987 Q18120 →
Q9ES08 0.987 Q9ES08 →
P40310 0.987 P40310 →
O97531 0.986 O97531 →
A8X8I4 0.986 A8X8I4 →
P48767 0.986 P48767 →
Q9ER47 0.986 Q9ER47 →
SLC8A1 Sodium/calcium exchanger 1 0.986 landscape →
O17185 0.986 O17185 →
O54852 0.986 O54852 →
P19334 0.985 P19334 →
P91682 0.985 P91682 →
P48765 0.985 P48765 →
Q9QUQ5 0.985 Q9QUQ5 →
Q96L42 0.984 Q96L42 →
Q63ZI0 0.984 Q63ZI0 →